secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO-PATH HOLDINGS, INC. (BPTH)
CIK:        0001133818
Form:       8-K
Filed at:   2024-04-04T23:59:59+00:00
Accession:  0001104659-24-043661
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bio-Path enters ATM agreement for up to $2M common stock offering
-----------------------------------------------------------------

- Entered At The Market Offering Agreement with H.C. Wainwright & Co. for up to $2.0M of common stock.
- Sales agent commission set at 3.0% of aggregate gross proceeds from each sale.
- Shares sold at market prices; Company not obligated to sell and may suspend or terminate.
- Offering made under effective shelf registration (File No. 333-265282) and prospectus supplement filed April 4, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1133818/000110465924043661/0001104659-24-043661-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1133818/000110465924043661/tm2411049d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-043661

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer